Agency Information Collection Request; 60-Day Public Comment Request, 6287-6288 [2023-01877]
Download as PDF
<![CDATA[
6287
Federal Register / Vol. 88, No. 20 / Tuesday, January 31, 2023 / Notices
Data Report, OMB No. 0915–0345
Revision.
Abstract: HRSA’s Ryan White HIV/
AIDS Program (RWHAP) AIDS Drug
Assistance Program (ADAP) is
authorized under Part B of the RWHAP
legislation, codified in sections 2611 to
2631 of the Public Health Service Act,
which provides grants to U.S. states and
territories. RWHAP ADAP is a state and
territory-administered program that
provides Food and Drug
Administration-approved medications
to low-income people with HIV who
have limited or no health coverage from
private insurance, Medicaid, or
Medicare. RWHAP ADAP funds may
also be used to purchase health care
coverage for eligible clients and for
services that enhance access, adherence,
and monitoring of drug treatments.
All 50 states, the District of Columbia,
Puerto Rico, Guam, the U.S. Virgin
Islands, and the five U.S. Pacific
Territories or Associated Jurisdictions
receive RWHAP Part B grant awards,
including funds for RWHAP ADAP.
RWHAP Part B reporting requirements
include the annual submission of an
ADAP Data Report (ADR), including a
Recipient Report and a Client Report.
The Recipient Report is a collection of
basic information about grant recipient
characteristics and policies including
program administration, purchasing
mechanisms, funding, and
expenditures. The Client Report is a
collection of client-level records (one
record for each client enrolled in the
RWHAP ADAP), which includes the
client’s encrypted unique identifier,
basic demographic data, enrollment
information, services received, and
clinical data.
HRSA is proposing two revisions and
one re-installment of questions to the
ADR Recipient and Client Reports to
reflect program practices and support
HRSA’s analysis and understanding of
program impact. Specifically, the
Recipient Report includes the following
proposed changes:
• Replacement of the Recertification
Date variable with the Last Date of
Eligibility Confirmation will remove the
previous 6 month recertification
requirement, which is no longer
required by policy, see Policy
Clarification Notice 21–02, and allow
Recipients to report the latest eligibility
confirmation date for existing clients;
• Reinstate a question that was
inadvertently removed from the 2021
ADR that is needed to assess the quality
of medication data; and
• Change the Data Universal
Numbering System (DUNS) number
variable to Unique Entity Identifier. On
April 4, 2022, the federal government
stopped using DUNs numbers, making it
less burdensome for entities to do
business with the federal government.
As a result, Recipients no longer have to
report the DUNs number in the ADR.
HRSA does not anticipate these
proposed revisions resulting in a change
in the reporting burden. New and
revised data elements require reporting
of information that should already be
collected by recipients to meet
legislative or programmatic
requirements for the proper oversight
and administration of the program.
A 60-day notice was published in the
Federal Register on November 9, 2022
(Vol. 87, No. 216, pp. 67702–03). No
comments were received.
Need and Proposed Use of the
Information: RWHAP requires the
submission of annual reports by the
Secretary of Health and Human Services
to the appropriate committees of
Congress. HRSA uses the ADR to
evaluate the national impact of the
RWHAP ADAP by providing
deidentified client-level data on
individuals being served, services being
delivered, and costs associated with
these services. The client-level data is
used to monitor health outcomes of
people with HIV receiving care and
treatment through the RWHAP ADAP,
to monitor the use of RWHAP ADAP
funds in addressing the HIV epidemic
and its impact on communities, and to
track progress toward achieving the
goals identified in the National HIV/
AIDS Strategy.
Likely Respondents: State ADAPs of
RWHAP Part B recipients.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
khammond on DSKJM1Z7X2PROD with NOTICES
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
Recipient Report ..................................................................
Client Report ........................................................................
54
54
1
1
54
54
6
81
324
4,374
Total ..............................................................................
54
........................
54
........................
4,698
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Maria G. Button,
Director, Executive Secretariat.
[Document Identifier OS–0990–0323]
[FR Doc. 2023–01917 Filed 1–30–23; 8:45 am]
BILLING CODE 4165–15–P
Agency Information Collection
Request; 60-Day Public Comment
Request
AGENCY:
ACTION:
VerDate Sep<11>2014
16:46 Jan 30, 2023
Jkt 259001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
E:\FR\FM\31JAN1.SGM
Office of the Secretary, HHS.
Notice.
31JAN1
6288
Federal Register / Vol. 88, No. 20 / Tuesday, January 31, 2023 / Notices
In compliance with the
requirement of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, is publishing the
following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be
received on or before April 3, 2023.
ADDRESSES: Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 264–0041 and PRA@HHS.GOV.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–0323 60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, PRA@
HHS.GOV or call (202) 264–0041 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
SUMMARY:
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection:
MedicalCountermeasures.gov.
Type of Collection: Reinstatement
without change.
OMB No.: OMB 0990–0323.
Abstract: (Department of Health and
Human Services, Administration for
Strategic Preparedness and Response
(ASPR).
The U.S. Government seeks
information from stakeholders on
available medical countermeasures in
development, with a particular interest
in products, technologies, and
capabilities that have progressed into or
beyond clinical trials, have established
large-scale cGMP manufacturing
capability, or utilize an approved
platform. Information regarding
diagnostics, therapeutics, vaccines, and
other products, technologies, or
capabilities relevant to respond to
public health emergencies are sought.
The TechWatch program, run by ASPR/
BARDA, provides the
Medicalcountermeasures.gov
bdr.hhs.gov portal as a single point of
entry for the submission of meeting
requests from interested stakeholders
with promising MCM products,
technologies, and capabilities.
ANNUALIZED BURDEN HOUR TABLE
Number of
respondents
Respondents
(if necessary)
1 .....................
Developers of medical countermeasures addressing naturally
occurring and intentional public
health threats.
350
1
8/60 ..................................................
47
Total ........
...........................................................
........................
350
...........................................................
47
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2023–01877 Filed 1–30–23; 8:45 am]
BILLING CODE 4150–37–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondents
Forms
(if necessary)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
16:46 Jan 30, 2023
Jkt 259001
Average burden
per response
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Research on Current Topics in Alzheimer’s
Disease and its Related Dementias.
Date: February 23–24, 2023.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mei Qin, Ph.D., MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5213,
Bethesda, MD 20892, 301–875–2215,
qinmei@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Antiviral
Drug Discovery and Molecular
Pharmacology.
Date: February 23, 2023.
Time: 9:30 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–827–5997, shinako.takada@
nih.gov.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Total burden
hours
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Acute Neural Injury and Epilepsy
Study Section.
Date: February 23–24, 2023.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
Immunity and Host Defense Study Section.
Date: February 23–24, 2023.
Time: 9:30 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Alok Mulky, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4203,
Bethesda, MD 20892, (301) 435–3566,
mulkya@mail.nih.gov.
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 88, Number 20 (Tuesday, January 31, 2023)]
[Notices]
[Pages 6287-6288]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01877]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[Document Identifier OS-0990-0323]
Agency Information Collection Request; 60-Day Public Comment
Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 6288]]
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995, the Office of the Secretary (OS), Department of Health and
Human Services, is publishing the following summary of a proposed
collection for public comment.
DATES: Comments on the ICR must be received on or before April 3, 2023.
ADDRESSES: Submit your comments to [email protected] or by calling
(202) 264-0041 and [email protected].
FOR FURTHER INFORMATION CONTACT: When submitting comments or requesting
information, please include the document identifier 0990-0323 60D and
project title for reference, to Sherrette A. Funn, email:
[email protected], [email protected] or call (202) 264-0041 the Reports
Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
Title of the Collection: MedicalCountermeasures.gov.
Type of Collection: Reinstatement without change.
OMB No.: OMB 0990-0323.
Abstract: (Department of Health and Human Services, Administration
for Strategic Preparedness and Response (ASPR).
The U.S. Government seeks information from stakeholders on
available medical countermeasures in development, with a particular
interest in products, technologies, and capabilities that have
progressed into or beyond clinical trials, have established large-scale
cGMP manufacturing capability, or utilize an approved platform.
Information regarding diagnostics, therapeutics, vaccines, and other
products, technologies, or capabilities relevant to respond to public
health emergencies are sought. The TechWatch program, run by ASPR/
BARDA, provides the Medicalcountermeasures.gov bdr.hhs.gov portal as a
single point of entry for the submission of meeting requests from
interested stakeholders with promising MCM products, technologies, and
capabilities.
Annualized Burden Hour Table
----------------------------------------------------------------------------------------------------------------
Number of
Forms (if necessary) Respondents (if Number of responses per Average burden Total burden
necessary) respondents respondents per response hours
----------------------------------------------------------------------------------------------------------------
1............................ Developers of 350 1 8/60........... 47
medical
countermeasures
addressing
naturally
occurring and
intentional
public health
threats.
----------------------------------------------------------------
Total.................... ................ .............. 350 ............... 47
----------------------------------------------------------------------------------------------------------------
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance Officer, Office of the
Secretary.
[FR Doc. 2023-01877 Filed 1-30-23; 8:45 am]
BILLING CODE 4150-37-P
